Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Calcium Supplementation May Benefit Lead Levels - JAMA Editorial

This article was originally published in The Tan Sheet

Executive Summary

Calcium intake impedes lead absorption and stops the body from accessing lead deposits in bones, Robert Heaney, MD, maintains in an editorial response to a study on lead content in calcium supplements.

You may also be interested in...



ConsumerLab.com Calcium Testing Uncovers USP Label Misuse

Three of four calcium products that failed ConsumerLab.com content tests were designated "USP" on labeling, according to results posted on the testing firm's Web site Sept. 6.

Lower Lead Limits For Calcium-Containing Products Shelved By FDA

FDA is not adopting new, lower lead limits for calcium-containing supplements and antacids at this time but "is actively investigating the feasibility of establishing lower limits," the agency tells the Council for Responsible Nutrition and the Consumer Healthcare Products Association in a Sept. 28 letter.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091673

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel